{"transactions":[{"id":674169,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-27T20:21:57.000Z","date":"2026-08-19","kind":"grant","planned":false,"acquired":true,"shares":6662,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents a restricted stock award that will vest in three equal annual installments on the first, second and third anniversaries of August 19, 2026."}],"balance_after":6662,"source":{"system":"sec-edgar","filing":"0001659625-26-000011","document":"wk-form4_1787862115.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000165962526000011/wk-form4_1787862115.xml","form_type":"4"}},{"id":1135297,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-05-23T20:07:33.000Z","date":"2025-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":155450,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time each stock option that was outstanding and unexercised immediately prior to the Effective Time with a per share exercise price of $18.00 or less was assumed by Parent and converted into an option to purchase a number of shares of Parent Common Stock equal to (i) the number of shares subject to the option immediately prior to the Effective Time, multiplied by (ii) the Exchange Ratio, with any fractional shares rounded down to the nearest whole share, which stock option shall have an exercise price equal to (i) the per share exercise price for shares subject to the corresponding Company stock option immediately prior to the Effective Time, divided by (ii) the Exchange Ratio, rounded up to the nearest whole cent."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/48 of the shares subject to the option vested on April 17, 2023 and 1/48 of the shares subject to the option vests in equal monthly installments thereafter, subject to the Reporting Person's continued service."}],"balance_after":0,"derivative":{"exercise_price":7.4345,"expiration_date":"2033-03-22","underlying":"Common Stock","underlying_shares":155450},"source":{"system":"sec-edgar","filing":"0001962918-25-000058","document":"wk-form4_1748030845.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000196291825000058/wk-form4_1748030845.xml","form_type":"4"}},{"id":1135296,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-05-23T20:07:33.000Z","date":"2025-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":92158,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time each stock option that was outstanding and unexercised immediately prior to the Effective Time with a per share exercise price of $18.00 or less was assumed by Parent and converted into an option to purchase a number of shares of Parent Common Stock equal to (i) the number of shares subject to the option immediately prior to the Effective Time, multiplied by (ii) the Exchange Ratio, with any fractional shares rounded down to the nearest whole share, which stock option shall have an exercise price equal to (i) the per share exercise price for shares subject to the corresponding Company stock option immediately prior to the Effective Time, divided by (ii) the Exchange Ratio, rounded up to the nearest whole cent."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of the shares subject to the option vest on the earlier of (i) June 7, 2025, or (ii) the day immediately preceding the next annual meeting of stockholders following the grant date of the option, subject to the Reporting Person's continued service as a director through the vesting date."}],"balance_after":0,"derivative":{"exercise_price":4.46,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":92158},"source":{"system":"sec-edgar","filing":"0001962918-25-000058","document":"wk-form4_1748030845.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000196291825000058/wk-form4_1748030845.xml","form_type":"4"}},{"id":1135295,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-23T20:07:33.000Z","date":"2025-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 6, 2025, ACELYRIN, Inc., a Delaware corporation (the \"Company\"), entered into an Agreement and Plan of Merger (as amended on April 20, 2025, the \"Merger Agreement\") with Alumis, Inc., a Delaware corporation (\"Parent\"), and Arrow Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, on May 21, 2025, Merger Sub merged with and into the Company (the \"Merger\"), with the Company surviving as a wholly owned subsidiary of Parent. At the effective time of the Merger (the \"Effective Time\"), each share of common stock, par value $0.00001 per share, of the Company issued and outstanding was converted into the right to receive 0.4814 (the \"Exchange Ratio\") shares of voting common stock of Parent, par value $0.0001 per share (\"Parent Common Stock\"), and cash in lieu of any fractional shares."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001962918-25-000058","document":"wk-form4_1748030845.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000196291825000058/wk-form4_1748030845.xml","form_type":"4"}},{"id":1483437,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2024-06-11T23:11:57.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":92158,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the shares subject to the option vest on the earlier of (i) June 7, 2025, or (ii) the day immediately preceding the next annual meeting of stockholders following the grant date of the option, subject to the Reporting Person's continued service as a director through the vesting date."}],"balance_after":92158,"derivative":{"exercise_price":4.46,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":92158},"source":{"system":"sec-edgar","filing":"0001962918-24-000091","document":"wk-form4_1718147510.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000196291824000091/wk-form4_1718147510.xml","form_type":"4"}},{"id":1638604,"issuer":{"id":6115,"kind":"organization","name":"Neumora Therapeutics, Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-16T21:15:11.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the option vest on the first anniversary measured from February 14, 2024 (the \"Vesting Commencement Date\"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":160000,"derivative":{"exercise_price":18.07,"expiration_date":"2034-02-13","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001610717-24-000065","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1885522/000161071724000065/form4.xml","form_type":"4"}},{"id":1638603,"issuer":{"id":6115,"kind":"organization","name":"Neumora Therapeutics, Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-02-16T21:15:11.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 25% of the RSUs vest annually measured from February 14, 2024 (the \"Vesting Commencement Date\"), such that 100% of the RSUs will be fully vested on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":462345,"source":{"system":"sec-edgar","filing":"0001610717-24-000065","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1885522/000161071724000065/form4.xml","form_type":"4"}},{"id":1777623,"issuer":{"id":6115,"kind":"organization","name":"Neumora Therapeutics, Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-09-20T01:47:02.000Z","date":"2023-09-19","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":12.6247,"value":189370.5,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $12.465 to $12.65, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by HG4KYC TRUST, of which Reporting Person is trustee."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001610717-23-000290","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1885522/000161071723000290/form4.xml","form_type":"4"}},{"id":1896718,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2023-05-12T01:06:24.000Z","date":"2023-05-09","kind":"other","planned":false,"acquired":true,"shares":155450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48 of the shares subject to the option vested on April 17, 2023 and 1/48 of the shares subject to the option vests in equal monthly installments thereafter, subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."}],"balance_after":155450,"derivative":{"exercise_price":7.4345,"expiration_date":"2033-03-22","underlying":"Common Stock","underlying_shares":155450},"source":{"system":"sec-edgar","filing":"0001209191-23-028878","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000120919123028878/doc4.xml","form_type":"4"}},{"id":1896717,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2023-05-12T01:06:24.000Z","date":"2023-05-09","kind":"other","planned":false,"acquired":false,"shares":155450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48 of the shares subject to the option vested on April 17, 2023 and 1/48 of the shares subject to the option vests in equal monthly installments thereafter, subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."}],"balance_after":0,"derivative":{"exercise_price":7.4345,"expiration_date":"2033-03-22","underlying":"Class A Common Stock","underlying_shares":155450},"source":{"system":"sec-edgar","filing":"0001209191-23-028878","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000120919123028878/doc4.xml","form_type":"4"}},{"id":1896716,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-12T01:06:24.000Z","date":"2023-05-09","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":18,"value":900000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares purchased through a directed share program in the Issuer's initial public offering of Common Stock (the \"IPO\")."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001209191-23-028878","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000120919123028878/doc4.xml","form_type":"4"}},{"id":2251435,"issuer":{"id":120922,"kind":"organization","name":"Aptinyx Inc.","symbol":"APTX"},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-31T16:31:02.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in ratable monthly installments over one year from the date of grant."}],"balance_after":40000,"derivative":{"exercise_price":0.5,"expiration_date":"2032-05-25","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-22-005908","document":"form4-05312022_040541.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674365/000141588922005908/form4-05312022_040541.xml","form_type":"4"}},{"id":66036,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Option (Right to Buy)","published_at":"2022-05-20T21:03:56.000Z","date":"2022-05-16","kind":"exercise","acquired":false,"shares":83960,"price":54.86,"value":4606045.6,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":54.86,"exercise_date":"2017-02-18","expiration_date":"2026-02-17","underlying":"Common Stock","underlying_shares":83960},"source":{"system":"sec-edgar","filing":"0001179110-22-003108","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911022003108/edgar.xml","form_type":"4/A","original_submission_date":"2022-05-18"}},{"id":66035,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-05-20T21:03:56.000Z","date":"2022-05-16","kind":"sale","acquired":false,"shares":83960,"price":155,"value":13013800.0,"ownership":{"direct":true},"balance_after":41623,"source":{"system":"sec-edgar","filing":"0001179110-22-003108","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911022003108/edgar.xml","form_type":"4/A","original_submission_date":"2022-05-18"}},{"id":66034,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-05-20T21:03:56.000Z","date":"2022-05-16","kind":"exercise","acquired":true,"shares":83960,"price":54.86,"value":4606045.6,"ownership":{"direct":true},"balance_after":125583,"source":{"system":"sec-edgar","filing":"0001179110-22-003108","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911022003108/edgar.xml","form_type":"4/A","original_submission_date":"2022-05-18"}},{"id":66040,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-05-20T21:00:54.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":100,"price":149.381,"value":14938.1,"ownership":{"direct":false,"nature":"In trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.38 to $149.39 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"The reporting person is trustee of a trust established for the benefit of his children. The reporting person disclaims beneficial ownership of all securities held by the trust."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Due to an administrative error, the original Form 4 filed on March 2, 2022 incorrectly reported that the 25,000 securities sold on March 1, 2022 were securities directly owned by the reporting person. Instead, the securities sold on that date were securities indirectly owned in trust by the reporting person. This amended Form 4 corrects that error."}],"balance_after":53500,"source":{"system":"sec-edgar","filing":"0001179110-22-003107","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911022003107/edgar.xml","form_type":"4/A","original_submission_date":"2022-03-02"}},{"id":66039,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-05-20T21:00:54.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":4000,"price":148.706,"value":594824.0,"ownership":{"direct":false,"nature":"In trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.37 to $148.96 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":53600,"source":{"system":"sec-edgar","filing":"0001179110-22-003107","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911022003107/edgar.xml","form_type":"4/A","original_submission_date":"2022-03-02"}},{"id":66038,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-05-20T21:00:54.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":5167,"price":147.6015,"value":762656.9505,"ownership":{"direct":false,"nature":"In trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.35 to $148.11 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":57600,"source":{"system":"sec-edgar","filing":"0001179110-22-003107","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911022003107/edgar.xml","form_type":"4/A","original_submission_date":"2022-03-02"}},{"id":66037,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-05-20T21:00:54.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":15733,"price":146.8105,"value":2309769.5965,"ownership":{"direct":false,"nature":"In trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.31 to $147.30 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":62767,"source":{"system":"sec-edgar","filing":"0001179110-22-003107","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911022003107/edgar.xml","form_type":"4/A","original_submission_date":"2022-03-02"}},{"id":66095,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Option (Right to Buy)","published_at":"2022-05-18T21:12:08.000Z","date":"2022-05-16","kind":"exercise","acquired":false,"shares":83960,"price":54.86,"value":4606045.6,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":54.86,"exercise_date":"2017-02-18","expiration_date":"2026-02-17","underlying":"Common Stock","underlying_shares":83960},"source":{"system":"sec-edgar","filing":"0001179110-22-003076","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911022003076/edgar.xml","form_type":"4"}},{"id":66094,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-05-18T21:12:08.000Z","date":"2022-05-16","kind":"sale","acquired":false,"shares":83960,"price":155,"value":13013800.0,"ownership":{"direct":true},"balance_after":16623,"source":{"system":"sec-edgar","filing":"0001179110-22-003076","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911022003076/edgar.xml","form_type":"4"}},{"id":66093,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-05-18T21:12:08.000Z","date":"2022-05-16","kind":"exercise","acquired":true,"shares":83960,"price":54.86,"value":4606045.6,"ownership":{"direct":true},"balance_after":100583,"source":{"system":"sec-edgar","filing":"0001179110-22-003076","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911022003076/edgar.xml","form_type":"4"}},{"id":69766,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-03-02T22:03:45.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":100,"price":149.381,"value":14938.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.38 to $149.39 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":16623,"source":{"system":"sec-edgar","filing":"0001179110-22-001923","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911022001923/edgar.xml","form_type":"4"}},{"id":69765,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-03-02T22:03:45.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":4000,"price":148.706,"value":594824.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.37 to $148.96 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":16723,"source":{"system":"sec-edgar","filing":"0001179110-22-001923","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911022001923/edgar.xml","form_type":"4"}},{"id":69764,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-03-02T22:03:45.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":5167,"price":147.6015,"value":762656.9505,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.35 to $148.11 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":20723,"source":{"system":"sec-edgar","filing":"0001179110-22-001923","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911022001923/edgar.xml","form_type":"4"}},{"id":69763,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-03-02T22:03:45.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":15733,"price":146.8105,"value":2309769.5965,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.31 to $147.30 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":25890,"source":{"system":"sec-edgar","filing":"0001179110-22-001923","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911022001923/edgar.xml","form_type":"4"}},{"id":69852,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-03-01T23:14:20.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":1101,"price":149.1441,"value":164207.6541,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.95 to $149.40 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":41623,"source":{"system":"sec-edgar","filing":"0001179110-22-001841","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911022001841/edgar.xml","form_type":"4"}},{"id":69851,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-03-01T23:14:20.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":8303,"price":148.6224,"value":1234011.7872,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.94 to $148.93 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":42724,"source":{"system":"sec-edgar","filing":"0001179110-22-001841","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911022001841/edgar.xml","form_type":"4"}},{"id":69850,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-03-01T23:14:20.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":5596,"price":147.5369,"value":825616.4924,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.89 to $147.88 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":51027,"source":{"system":"sec-edgar","filing":"0001179110-22-001841","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911022001841/edgar.xml","form_type":"4"}},{"id":69849,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-03-01T23:14:20.000Z","date":"2022-02-25","kind":"tax_withholding","acquired":false,"shares":30156,"price":149.54,"value":4509528.24,"ownership":{"direct":true},"balance_after":56623,"source":{"system":"sec-edgar","filing":"0001179110-22-001841","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911022001841/edgar.xml","form_type":"4"}},{"id":70245,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Option (right to buy)","published_at":"2022-02-22T22:39:33.000Z","date":"2022-02-17","kind":"grant","acquired":true,"shares":30647,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 10,216 on February 17, 2023, 10,216 on February 17, 2024, and 10,215 on February 17, 2025."}],"balance_after":30647,"derivative":{"exercise_price":144.54,"exercise_date":"2023-02-17","expiration_date":"2032-02-16","underlying":"Common Stock","underlying_shares":30647},"source":{"system":"sec-edgar","filing":"0001179110-22-001513","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911022001513/edgar.xml","form_type":"4"}},{"id":70244,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-02-22T22:39:33.000Z","date":"2022-02-17","kind":"grant","acquired":true,"shares":8701,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 18, 2021. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2022."}],"balance_after":86779,"source":{"system":"sec-edgar","filing":"0001179110-22-001513","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911022001513/edgar.xml","form_type":"4"}},{"id":70243,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-02-22T22:39:33.000Z","date":"2022-02-17","kind":"grant","acquired":true,"shares":14722,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 20, 2020. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2022."}],"balance_after":78078,"source":{"system":"sec-edgar","filing":"0001179110-22-001513","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911022001513/edgar.xml","form_type":"4"}},{"id":70242,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-02-22T22:39:33.000Z","date":"2022-02-17","kind":"grant","acquired":true,"shares":7972,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 21, 2019. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2022."}],"balance_after":63356,"source":{"system":"sec-edgar","filing":"0001179110-22-001513","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911022001513/edgar.xml","form_type":"4"}},{"id":70241,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-02-22T22:39:33.000Z","date":"2022-02-17","kind":"grant","acquired":true,"shares":36673,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 21, 2019. The award is subject to performance-vesting restrictions based on earnings per share and relative total shareholder return. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors Board of Directors. The shares will be issued to the reporting person on February 28, 2022."}],"balance_after":55384,"source":{"system":"sec-edgar","filing":"0001179110-22-001513","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911022001513/edgar.xml","form_type":"4"}},{"id":80826,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2021-09-10T21:01:48.000Z","date":"2021-09-07","kind":"gift","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"In trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reporting person is trustee of a trust established for the benefit of his children. The reporting person disclaims beneficial ownership of all securities held by the trust."}],"balance_after":78500,"source":{"system":"sec-edgar","filing":"0001179110-21-008720","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911021008720/edgar.xml","form_type":"4"}},{"id":80825,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2021-09-10T21:01:48.000Z","date":"2021-09-07","kind":"gift","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":18711,"source":{"system":"sec-edgar","filing":"0001179110-21-008720","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911021008720/edgar.xml","form_type":"4"}},{"id":2689027,"issuer":{"id":120922,"kind":"organization","name":"Aptinyx Inc.","symbol":"APTX"},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-01T16:36:14.000Z","date":"2021-05-27","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in ratable monthly installments over one year from the date of grant."}],"balance_after":40000,"derivative":{"exercise_price":2.59,"expiration_date":"2031-05-26","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-21-002740","document":"form4-06012021_010656.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674365/000141588921002740/form4-06012021_010656.xml","form_type":"4"}},{"id":92081,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2021-03-03T01:34:17.000Z","date":"2021-02-28","kind":"tax_withholding","acquired":false,"shares":22833,"price":107.74,"value":2460027.42,"ownership":{"direct":true},"balance_after":48711,"source":{"system":"sec-edgar","filing":"0001179110-21-002611","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911021002611/edgar.xml","form_type":"4"}},{"id":92726,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Option(right to buy)","published_at":"2021-02-22T23:25:55.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":49068,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 16,356 on February 18, 2022, 16,356 on February 18, 2023, and 16,356 on February 18, 2024."}],"balance_after":49068,"derivative":{"exercise_price":105.92,"exercise_date":"2022-02-18","expiration_date":"2031-02-17","underlying":"Common Stock","underlying_shares":49068},"source":{"system":"sec-edgar","filing":"0001179110-21-002053","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911021002053/edgar.xml","form_type":"4"}},{"id":92725,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2021-02-22T23:25:55.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":14724,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 20, 2020. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2021."}],"balance_after":71544,"source":{"system":"sec-edgar","filing":"0001179110-21-002053","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911021002053/edgar.xml","form_type":"4"}},{"id":92724,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2021-02-22T23:25:55.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":7972,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 21, 2019. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2021."}],"balance_after":56820,"source":{"system":"sec-edgar","filing":"0001179110-21-002053","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911021002053/edgar.xml","form_type":"4"}},{"id":92723,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2021-02-22T23:25:55.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":6555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 15, 2018. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2021."}],"balance_after":48848,"source":{"system":"sec-edgar","filing":"0001179110-21-002053","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911021002053/edgar.xml","form_type":"4"}},{"id":92722,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2021-02-22T23:25:55.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":22287,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 15, 2018. The award is subject to performance-vesting restrictions based on earnings per share and relative total shareholder return. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors Board of Directors. The shares will be issued to the reporting person on February 28, 2021."}],"balance_after":42293,"source":{"system":"sec-edgar","filing":"0001179110-21-002053","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911021002053/edgar.xml","form_type":"4"}},{"id":2920678,"issuer":{"id":120922,"kind":"organization","name":"Aptinyx Inc.","symbol":"APTX"},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-05T16:31:38.000Z","date":"2020-12-31","kind":"grant","acquired":true,"shares":5339,"price":2.224,"value":11873.936,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take equity awards in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation\nplan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the\ngrant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested at time of grant."}],"balance_after":5339,"derivative":{"exercise_price":3.46,"expiration_date":"2030-12-30","underlying":"Common Stock","underlying_shares":5339},"source":{"system":"sec-edgar","filing":"0001415889-21-000088","document":"form4-01052021_040107.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674365/000141588921000088/form4-01052021_040107.xml","form_type":"4"}},{"id":97991,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock, $0.01 par shar","published_at":"2020-11-24T22:34:39.000Z","date":"2020-11-20","kind":"sale","acquired":false,"shares":33100,"price":99.49,"value":3293119.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.00 to $99.88, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":20006,"source":{"system":"sec-edgar","filing":"0001179110-20-011342","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911020011342/edgar.xml","form_type":"4"}},{"id":97990,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock, $0.01 par share","published_at":"2020-11-24T22:34:39.000Z","date":"2020-11-20","kind":"sale","acquired":false,"shares":6900,"price":98.83,"value":681927.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.65 to $98.98, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":53106,"source":{"system":"sec-edgar","filing":"0001179110-20-011342","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911020011342/edgar.xml","form_type":"4"}},{"id":3016356,"issuer":{"id":120922,"kind":"organization","name":"Aptinyx Inc.","symbol":"APTX"},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-02T15:05:17.000Z","date":"2020-09-30","kind":"grant","acquired":true,"shares":5490,"price":2.163,"value":11874.87,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take equity awards in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation\nplan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the\ngrant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested at time of grant."}],"balance_after":5490,"derivative":{"exercise_price":3.38,"expiration_date":"2030-09-29","underlying":"Common Stock","underlying_shares":5490},"source":{"system":"sec-edgar","filing":"0001415889-20-002399","document":"form4-10022020_031006.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674365/000141588920002399/form4-10022020_031006.xml","form_type":"4"}},{"id":3092032,"issuer":{"id":120922,"kind":"organization","name":"Aptinyx Inc.","symbol":"APTX"},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-02T16:06:34.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":4051,"price":2.677,"value":10844.527,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take equity awards in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation\nplan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the\ngrant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested at time of grant."}],"balance_after":4051,"derivative":{"exercise_price":4.17,"expiration_date":"2030-06-29","underlying":"Common Stock","underlying_shares":4051},"source":{"system":"sec-edgar","filing":"0001415889-20-001796","document":"form4-07022020_040758.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674365/000141588920001796/form4-07022020_040758.xml","form_type":"4"}},{"id":3137367,"issuer":{"id":120922,"kind":"organization","name":"Aptinyx Inc.","symbol":"APTX"},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-22T16:11:08.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in ratable monthly installments over one year from the date of grant."}],"balance_after":40000,"derivative":{"exercise_price":3.84,"expiration_date":"2030-05-19","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001104659-20-065362","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674365/000110465920065362/a4.xml","form_type":"4"}},{"id":105307,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock, $0.01 par share","published_at":"2020-04-24T21:10:19.000Z","date":"2020-04-06","kind":"gift","acquired":true,"shares":18500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"In trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reporting person is trustee of a trust established for the benefit of his children. The reporting person disclaims beneficial ownership of all securities held by the trust."}],"balance_after":48500,"source":{"system":"sec-edgar","filing":"0001179110-20-005099","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911020005099/edgar.xml","form_type":"4"}},{"id":105306,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock, $0.01 par share","published_at":"2020-04-24T21:10:19.000Z","date":"2020-04-06","kind":"gift","acquired":false,"shares":18500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":60006,"source":{"system":"sec-edgar","filing":"0001179110-20-005099","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911020005099/edgar.xml","form_type":"4"}},{"id":3186708,"issuer":{"id":120922,"kind":"organization","name":"Aptinyx Inc.","symbol":"APTX"},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-02T16:24:02.000Z","date":"2020-03-31","kind":"grant","acquired":true,"shares":7374,"price":1.356,"value":9999.144,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take equity awards in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested at time of grant."}],"balance_after":7374,"derivative":{"exercise_price":2.16,"expiration_date":"2030-03-30","underlying":"Common Stock","underlying_shares":7374},"source":{"system":"sec-edgar","filing":"0001567619-20-007431","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674365/000156761920007431/doc1.xml","form_type":"4"}},{"id":106574,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2020-03-03T21:53:48.000Z","date":"2020-02-28","kind":"tax_withholding","acquired":false,"shares":26038,"price":85.42,"value":2224165.96,"ownership":{"direct":true},"balance_after":78506,"source":{"system":"sec-edgar","filing":"0001179110-20-002855","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911020002855/edgar.xml","form_type":"4"}},{"id":107145,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Option (right to buy)","published_at":"2020-02-24T23:02:33.000Z","date":"2020-02-20","kind":"grant","acquired":true,"shares":96563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 32,188 on February 20, 2021, 32,188 on February 20, 2022, and 32,187 on February 20, 2023."}],"balance_after":96563,"derivative":{"exercise_price":93.5,"exercise_date":"2021-02-20","expiration_date":"2030-02-19","underlying":"Common Stock","underlying_shares":96563},"source":{"system":"sec-edgar","filing":"0001179110-20-002135","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911020002135/edgar.xml","form_type":"4"}},{"id":107144,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2020-02-24T23:02:33.000Z","date":"2020-02-20","kind":"grant","acquired":true,"shares":7972,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 21, 2019. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2020."}],"balance_after":104544,"source":{"system":"sec-edgar","filing":"0001179110-20-002135","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911020002135/edgar.xml","form_type":"4"}},{"id":107143,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2020-02-24T23:02:33.000Z","date":"2020-02-20","kind":"grant","acquired":true,"shares":6555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 15, 2018. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2020."}],"balance_after":96572,"source":{"system":"sec-edgar","filing":"0001179110-20-002135","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911020002135/edgar.xml","form_type":"4"}},{"id":107142,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2020-02-24T23:02:33.000Z","date":"2020-02-20","kind":"grant","acquired":true,"shares":11730,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 16, 2017. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2020."}],"balance_after":90017,"source":{"system":"sec-edgar","filing":"0001179110-20-002135","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911020002135/edgar.xml","form_type":"4"}},{"id":107141,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2020-02-24T23:02:33.000Z","date":"2020-02-20","kind":"grant","acquired":true,"shares":32524,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 16, 2017. The award is subject to performance-vesting restrictions based on earnings per share and relative total shareholder return. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2020."}],"balance_after":78287,"source":{"system":"sec-edgar","filing":"0001179110-20-002135","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911020002135/edgar.xml","form_type":"4"}},{"id":3311643,"issuer":{"id":120922,"kind":"organization","name":"Aptinyx Inc.","symbol":"APTX"},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01","published_at":"2020-01-14T16:19:22.000Z","date":"2020-01-10","kind":"purchase","acquired":true,"shares":25000,"price":3,"value":75000.0,"ownership":{"direct":false,"nature":"In trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reporting person is trustee of a trust established for the benefit of his children. The reporting person disclaims beneficial ownership of all securities held by the trust."}],"balance_after":125000,"source":{"system":"sec-edgar","filing":"0001567619-20-001013","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674365/000156761920001013/doc1.xml","form_type":"4"}},{"id":3323332,"issuer":{"id":120922,"kind":"organization","name":"Aptinyx Inc.","symbol":"APTX"},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-03T16:24:06.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":4668,"price":2.142,"value":9998.856,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take equity awards in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested at time of grant."}],"balance_after":4668,"derivative":{"exercise_price":3.42,"expiration_date":"2029-12-30","underlying":"Common Stock","underlying_shares":4668},"source":{"system":"sec-edgar","filing":"0001567619-20-000342","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674365/000156761920000342/doc1.xml","form_type":"4"}},{"id":3396682,"issuer":{"id":120922,"kind":"organization","name":"Aptinyx Inc.","symbol":"APTX"},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01","published_at":"2019-10-07T16:36:49.000Z","date":"2019-10-04","kind":"gift","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"In trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reporting person is trustee of a trust established for the benefit of his children. The reporting person disclaims beneficial ownership of all securities held by the trust."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001567619-19-019304","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674365/000156761919019304/doc1.xml","form_type":"4"}},{"id":3396681,"issuer":{"id":120922,"kind":"organization","name":"Aptinyx Inc.","symbol":"APTX"},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01","published_at":"2019-10-07T16:36:49.000Z","date":"2019-10-04","kind":"gift","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-19-019304","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674365/000156761919019304/doc1.xml","form_type":"4"}},{"id":3401160,"issuer":{"id":120922,"kind":"organization","name":"Aptinyx Inc.","symbol":"APTX"},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-02T16:28:32.000Z","date":"2019-09-30","kind":"grant","acquired":true,"shares":4419,"price":2.082,"value":9200.358,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take equity awards in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested at time of grant."}],"balance_after":4419,"derivative":{"exercise_price":3.49,"expiration_date":"2029-09-29","underlying":"Common Stock","underlying_shares":4419},"source":{"system":"sec-edgar","filing":"0001567619-19-019078","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674365/000156761919019078/doc1.xml","form_type":"4"}},{"id":114089,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2019-08-16T20:11:04.000Z","date":"2019-08-14","kind":"gift","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"In trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reporting person is trustee of a trust established for the benefit of his children.  The reporting person disclaims beneficial ownership of all securities held by the trust."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001179110-19-009582","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911019009582/edgar.xml","form_type":"4"}},{"id":114088,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2019-08-16T20:11:04.000Z","date":"2019-08-14","kind":"gift","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":45763,"source":{"system":"sec-edgar","filing":"0001179110-19-009582","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911019009582/edgar.xml","form_type":"4"}},{"id":114917,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2019-07-31T20:46:11.000Z","date":"2019-07-29","kind":"purchase","acquired":true,"shares":30000,"price":67.2795,"value":2018385.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $67.23 to $67.32, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":75763,"source":{"system":"sec-edgar","filing":"0001179110-19-008937","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911019008937/edgar.xml","form_type":"4"}},{"id":3471385,"issuer":{"id":120922,"kind":"organization","name":"Aptinyx Inc.","symbol":"APTX"},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-02T17:01:02.000Z","date":"2019-06-28","kind":"grant","acquired":true,"shares":2649,"price":1.982,"value":5250.318,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take equity awards in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested at time of grant."}],"balance_after":2649,"derivative":{"exercise_price":3.34,"expiration_date":"2029-06-27","underlying":"Common Stock","underlying_shares":2649},"source":{"system":"sec-edgar","filing":"0001104659-19-039056","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674365/000110465919039056/a4.xml","form_type":"4"}},{"id":3521164,"issuer":{"id":120922,"kind":"organization","name":"Aptinyx Inc.","symbol":"APTX"},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-17T17:00:49.000Z","date":"2019-05-15","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests over a three-year period with one-third of the option vesting on the first anniversary of the date of grant and the remaining two-thirds vesting in ratable monthly installments thereafter."}],"balance_after":80000,"derivative":{"exercise_price":3.73,"expiration_date":"2029-05-14","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001104659-19-030314","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674365/000110465919030314/a4.xml","form_type":"4"}},{"id":3533667,"issuer":{"id":120922,"kind":"organization","name":"Aptinyx Inc.","symbol":"APTX"},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-09T10:01:42.000Z","date":"2019-05-08","kind":"purchase","acquired":true,"shares":96580,"price":3.86,"value":372798.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.785 to $3.90, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001104659-19-028074","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674365/000110465919028074/a4.xml","form_type":"4"}},{"id":3533666,"issuer":{"id":120922,"kind":"organization","name":"Aptinyx Inc.","symbol":"APTX"},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-09T10:01:42.000Z","date":"2019-05-07","kind":"purchase","acquired":true,"shares":3420,"price":3.75,"value":12825.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.73 to $3.75, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":3420,"source":{"system":"sec-edgar","filing":"0001104659-19-028074","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674365/000110465919028074/a4.xml","form_type":"4"}},{"id":118970,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2019-03-04T21:55:42.000Z","date":"2019-02-28","kind":"tax_withholding","acquired":false,"shares":22956,"price":79.41,"value":1822935.96,"ownership":{"direct":true},"balance_after":45763,"source":{"system":"sec-edgar","filing":"0001179110-19-003080","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911019003080/edgar.xml","form_type":"4"}},{"id":119485,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Option (Right to buy)","published_at":"2019-02-22T22:19:39.000Z","date":"2019-02-21","kind":"grant","acquired":true,"shares":49065,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 16,355 on February 21, 2020, 16,355 on February 21, 2021, and 16,355 on February 21, 2022."}],"balance_after":49065,"derivative":{"exercise_price":79.02,"exercise_date":"2020-02-21","expiration_date":"2029-02-20","underlying":"Common Stock","underlying_shares":49065},"source":{"system":"sec-edgar","filing":"0001179110-19-002368","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911019002368/edgar.xml","form_type":"4"}},{"id":119484,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2019-02-22T22:19:39.000Z","date":"2019-02-21","kind":"grant","acquired":true,"shares":6555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 15, 2018. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2019."}],"balance_after":68719,"source":{"system":"sec-edgar","filing":"0001179110-19-002368","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911019002368/edgar.xml","form_type":"4"}},{"id":119483,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2019-02-22T22:19:39.000Z","date":"2019-02-21","kind":"grant","acquired":true,"shares":11730,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 16, 2017. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2019."}],"balance_after":62164,"source":{"system":"sec-edgar","filing":"0001179110-19-002368","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911019002368/edgar.xml","form_type":"4"}},{"id":119482,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2019-02-22T22:19:39.000Z","date":"2019-02-21","kind":"grant","acquired":true,"shares":14035,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 18, 2016. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2019."}],"balance_after":50434,"source":{"system":"sec-edgar","filing":"0001179110-19-002368","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911019002368/edgar.xml","form_type":"4"}},{"id":119481,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2019-02-22T22:19:39.000Z","date":"2019-02-21","kind":"grant","acquired":true,"shares":19495,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 18, 2016. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2019."}],"balance_after":36399,"source":{"system":"sec-edgar","filing":"0001179110-19-002368","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911019002368/edgar.xml","form_type":"4"}},{"id":121927,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2018-12-11T21:59:15.000Z","date":"2018-12-09","kind":"tax_withholding","acquired":false,"shares":13446,"price":86.96,"value":1169264.16,"ownership":{"direct":true},"balance_after":16904,"source":{"system":"sec-edgar","filing":"0001179110-18-013700","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911018013700/edgar.xml","form_type":"4"}},{"id":122184,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2018-11-30T22:22:32.000Z","date":"2018-11-29","kind":"sale","acquired":false,"shares":42450,"price":90.1046,"value":3824940.27,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.00 to $90.24, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":30350,"source":{"system":"sec-edgar","filing":"0001179110-18-013337","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911018013337/edgar.xml","form_type":"4"}},{"id":131355,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2018-03-02T22:29:50.000Z","date":"2018-02-28","kind":"tax_withholding","acquired":false,"shares":17418,"price":118.26,"value":2059852.68,"ownership":{"direct":true},"balance_after":72800,"source":{"system":"sec-edgar","filing":"0001179110-18-003336","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911018003336/edgar.xml","form_type":"4"}},{"id":132318,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Option (right to buy)","published_at":"2018-02-16T22:54:06.000Z","date":"2018-02-15","kind":"grant","acquired":true,"shares":35440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exercisable in annual increments of 11,814 on February 15, 2019, 11,813 on February 15, 2020, and 11,813 on February 15, 2021."}],"balance_after":35440,"derivative":{"exercise_price":114.36,"exercise_date":"2019-02-15","expiration_date":"2028-02-14","underlying":"Common Stock","underlying_shares":35440},"source":{"system":"sec-edgar","filing":"0001179110-18-002298","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911018002298/edgar.xml","form_type":"4"}},{"id":132317,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2018-02-16T22:54:06.000Z","date":"2018-02-15","kind":"grant","acquired":true,"shares":11730,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of AbbVie common stock issued under a performance-vested restricted stock unit award granted to the reporting person on February 16, 2017. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2018."}],"balance_after":90218,"source":{"system":"sec-edgar","filing":"0001179110-18-002298","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911018002298/edgar.xml","form_type":"4"}},{"id":132316,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2018-02-16T22:54:06.000Z","date":"2018-02-15","kind":"grant","acquired":true,"shares":13552,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 16, 2017. The award is subject to performance-vesting restrictions based on adjusted earnings per share and relative total shareholder return measures. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2018."}],"balance_after":78488,"source":{"system":"sec-edgar","filing":"0001179110-18-002298","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911018002298/edgar.xml","form_type":"4"}},{"id":132315,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2018-02-16T22:54:06.000Z","date":"2018-02-15","kind":"grant","acquired":true,"shares":14034,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of AbbVie common stock issued under a performance-vested restricted stock unit award granted to the reporting person on February 18, 2016. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2018."}],"balance_after":64936,"source":{"system":"sec-edgar","filing":"0001179110-18-002298","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911018002298/edgar.xml","form_type":"4"}},{"id":134508,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2017-12-11T22:23:03.000Z","date":"2017-12-09","kind":"tax_withholding","acquired":false,"shares":14235,"price":95.95,"value":1365848.25,"ownership":{"direct":true},"balance_after":50902,"source":{"system":"sec-edgar","filing":"0001179110-17-015227","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911017015227/edgar.xml","form_type":"4"}},{"id":135994,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2017-10-31T21:04:42.000Z","date":"2017-10-30","kind":"sale","acquired":false,"shares":100,"price":92.02,"value":9202.0,"ownership":{"direct":true},"balance_after":65137,"source":{"system":"sec-edgar","filing":"0001179110-17-013599","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911017013599/edgar.xml","form_type":"4"}},{"id":135993,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2017-10-31T21:04:42.000Z","date":"2017-10-30","kind":"sale","acquired":false,"shares":4482,"price":91.2203,"value":408849.3846,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.95 to $91.84, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":65237,"source":{"system":"sec-edgar","filing":"0001179110-17-013599","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911017013599/edgar.xml","form_type":"4"}},{"id":135992,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2017-10-31T21:04:42.000Z","date":"2017-10-30","kind":"sale","acquired":false,"shares":11568,"price":90.4922,"value":1046813.7696,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.94 to $90.94, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":69719,"source":{"system":"sec-edgar","filing":"0001179110-17-013599","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911017013599/edgar.xml","form_type":"4"}},{"id":135991,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2017-10-31T21:04:42.000Z","date":"2017-10-30","kind":"sale","acquired":false,"shares":2150,"price":89.3823,"value":192171.945,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.93 to $89.86, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":81287,"source":{"system":"sec-edgar","filing":"0001179110-17-013599","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911017013599/edgar.xml","form_type":"4"}},{"id":138492,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2017-08-02T21:06:02.000Z","date":"2017-07-31","kind":"sale","acquired":false,"shares":200,"price":70.45,"value":14090.0,"ownership":{"direct":true},"balance_after":83437,"source":{"system":"sec-edgar","filing":"0001179110-17-010983","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911017010983/edgar.xml","form_type":"4"}},{"id":138491,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common stock, par value $0.01","published_at":"2017-08-02T21:06:02.000Z","date":"2017-07-31","kind":"sale","acquired":false,"shares":100,"price":70.37,"value":7037.0,"ownership":{"direct":true},"balance_after":83637,"source":{"system":"sec-edgar","filing":"0001179110-17-010983","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911017010983/edgar.xml","form_type":"4"}},{"id":138521,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2017-08-02T21:05:47.000Z","date":"2017-07-31","kind":"sale","acquired":false,"shares":100,"price":70.34,"value":7034.0,"ownership":{"direct":true},"balance_after":83737,"source":{"system":"sec-edgar","filing":"0001179110-17-010982","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":29,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911017010982/edgar.xml","form_type":"4"}},{"id":138520,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2017-08-02T21:05:47.000Z","date":"2017-07-31","kind":"sale","acquired":false,"shares":100,"price":70.29,"value":7029.0,"ownership":{"direct":true},"balance_after":83837,"source":{"system":"sec-edgar","filing":"0001179110-17-010982","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":28,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911017010982/edgar.xml","form_type":"4"}},{"id":138519,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2017-08-02T21:05:47.000Z","date":"2017-07-31","kind":"sale","acquired":false,"shares":200,"price":70.25,"value":14050.0,"ownership":{"direct":true},"balance_after":83937,"source":{"system":"sec-edgar","filing":"0001179110-17-010982","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":27,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911017010982/edgar.xml","form_type":"4"}},{"id":138518,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2017-08-02T21:05:47.000Z","date":"2017-07-31","kind":"sale","acquired":false,"shares":600,"price":70.23,"value":42138.0,"ownership":{"direct":true},"balance_after":84137,"source":{"system":"sec-edgar","filing":"0001179110-17-010982","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911017010982/edgar.xml","form_type":"4"}},{"id":138517,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2017-08-02T21:05:47.000Z","date":"2017-07-31","kind":"sale","acquired":false,"shares":400,"price":70.22,"value":28088.0,"ownership":{"direct":true},"balance_after":84737,"source":{"system":"sec-edgar","filing":"0001179110-17-010982","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911017010982/edgar.xml","form_type":"4"}},{"id":138516,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2017-08-02T21:05:47.000Z","date":"2017-07-31","kind":"sale","acquired":false,"shares":700,"price":70.21,"value":49147.0,"ownership":{"direct":true},"balance_after":85137,"source":{"system":"sec-edgar","filing":"0001179110-17-010982","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911017010982/edgar.xml","form_type":"4"}},{"id":138515,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2017-08-02T21:05:47.000Z","date":"2017-07-31","kind":"sale","acquired":false,"shares":500,"price":70.2,"value":35100.0,"ownership":{"direct":true},"balance_after":85837,"source":{"system":"sec-edgar","filing":"0001179110-17-010982","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911017010982/edgar.xml","form_type":"4"}},{"id":138514,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2017-08-02T21:05:47.000Z","date":"2017-07-31","kind":"sale","acquired":false,"shares":1200,"price":70.19,"value":84228.0,"ownership":{"direct":true},"balance_after":86337,"source":{"system":"sec-edgar","filing":"0001179110-17-010982","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911017010982/edgar.xml","form_type":"4"}},{"id":138513,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2017-08-02T21:05:47.000Z","date":"2017-07-31","kind":"sale","acquired":false,"shares":300,"price":70.185,"value":21055.5,"ownership":{"direct":true},"balance_after":87537,"source":{"system":"sec-edgar","filing":"0001179110-17-010982","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1659625/000117911017010982/edgar.xml","form_type":"4"}}],"next_cursor":"2017-08-02T21:05:47.000000Z,138513"}